Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Femiforte
- Development stage
- Unknown
- Lead developer
- Charak
- Administration
- Oral
01
Overview
Femiforte is a proprietary Ayurvedic herbo-mineral formulation developed and manufactured by Charak Pharma. It is indicated for the treatment of leucorrhoea (excessive white vaginal discharge) of infectious or non-infectious origin, as well as recurrent vaginitis. The formulation contains a blend of traditional Ayurvedic herbs and minerals, including Ashoka (Saraca indica), Lodhra (Symplocos racemosa), Daruharidra (Berberis aristata), Guduchi (Tinospora cordifolia), and Shatavari (Asparagus racemosus). These ingredients act synergistically as natural astringents to reduce excessive vaginal discharge, restore optimal vaginal pH, and exert antimicrobial, anti-inflammatory, and immune-stimulating effects to prevent recurrent infections.
- Brand names
- Femiforte
- Other names
- Femiforte Tablet
Beyond the preview
Go deeper on Femiforte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Femiforte.